<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003741'>Congenital muscular dystrophy</z:hpo> (CMD) is a clinically and genetically <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of inherited <z:e sem="disease" ids="C0026848" disease_type="Disease or Syndrome" abbrv="">muscle disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In patients, <z:hpo ids='HP_0001324'>muscle weakness</z:hpo> is usually present at or shortly after birth and is progressive in nature </plain></SENT>
<SENT sid="2" pm="."><plain>Merosin deficient <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e>) is a form of CMD caused by a defect in the laminin-α2 gene (LAMA2) </plain></SENT>
<SENT sid="3" pm="."><plain>Laminin-α2 is an extracellular matrix protein that interacts with the dystrophin-dystroglycan (DGC) complex in membranes providing stability to muscle fibers </plain></SENT>
<SENT sid="4" pm="."><plain>In an <z:chebi fb="0" ids="23995">N-ethyl-N-nitrosourea</z:chebi> mutagenesis screen to develop zebrafish models of <z:e sem="disease" ids="C0027868" disease_type="Disease or Syndrome" abbrv="">neuromuscular diseases</z:e>, we identified a mutant fish that exhibits severe <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> early in development </plain></SENT>
<SENT sid="5" pm="."><plain>Genetic mapping identified a splice site mutation in the lama2 gene </plain></SENT>
<SENT sid="6" pm="."><plain>This splice site is highly conserved in humans and this mutation results in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">mis</z:e>-splicing of <z:chebi fb="40" ids="33697">RNA</z:chebi> and a loss of protein function </plain></SENT>
<SENT sid="7" pm="."><plain>Homozygous lama2 mutant zebrafish, designated lama2(cl501/cl501), exhibited reduced motor function and progressive degeneration of skeletal muscles and died at 8-15 days post fertilization </plain></SENT>
<SENT sid="8" pm="."><plain>The skeletal muscles exhibited damaged myosepta and detachment of myofibers in the affected fish </plain></SENT>
<SENT sid="9" pm="."><plain>Laminin-α2 deficiency also resulted in growth defects in the brain and eye of the mutant fish </plain></SENT>
<SENT sid="10" pm="."><plain>This laminin-α2 deficient mutant fish represents a novel <z:e sem="disease" ids="C0684309" disease_type="Experimental Model of Disease" abbrv="">disease model</z:e> to develop therapies for modulating splicing defects in <z:hpo ids='HP_0003741'>congenital muscular dystrophies</z:hpo> and to restore the muscle function in human patients with CMD </plain></SENT>
</text></document>